Cancer Drug Discovery and Development

Antiangiogenic Agents in Cancer Therapy

Editors: Teicher, Beverly A., Ellis, Lee M. (Eds.)

  • Current perspectives on state-of-the-art therapies
  • Contains chapters specific to angiogenesis and antiangiogenic treatment of many malignant diseases
see more benefits

Buy this book

eBook $249.00
price for USA (gross)
  • ISBN 978-1-59745-184-0
  • Digitally watermarked, DRM-free
  • Included format: PDF
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover $319.00
price for USA
  • ISBN 978-1-58829-870-6
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
About this book

Antiangiogenesis remains a dynamic and evolving field in oncology. New therapeutic targets continue to emerge followed by the rapid development of new therapeutic agents to be investigated in clinical trials. Optimizing the therapeutic potential of antiangiogenic agents in combination with the other therapies in the armamentarium to fight cancer will be an on-going challenge. Antiangiogenic Agents in Cancer Therapy, Second Edition provides a current, up-dated perspective on the state of the art of angiogenesis and therapy with a compendium of scientific findings and approaches to the study of angiogenesis in cancer.  Leaders in the field present chapters on such topics as the environmental influences and the genetic and physiologic abnormalities that mediate angiogenesis and its role in the progression of malignant disease, working models of tumor angiogenesis, and the role of angiogenesis inhibition in the therapy of malignant disease in humans. 

Comprehensive and cutting-edge, Antiangiogenic Agents in Cancer Therapy, Second Edition is an ideal, valuable guide to the most recent advances in the field, and a collection that will be useful for many years to come.

Reviews

From the reviews of the second edition:

"This is a second edition of a well-accepted text on angiogenesis and antiangiogenic agents, particularly on their use in cancer therapy. In addition to the editors, a large number of outstanding investigators have contributed to this book. … This edition is highly recommended to all of those involved in research or the clinical practice of oncology." (Julian L. Ambrus and Clara M. Ambrus, The Journal of Medicine, March, 2008)


Table of contents (31 chapters)

  • Vascular Endothelial Growth Factor Family and Its Receptors

    Hicklin, Daniel J.

    Pages 3-26

  • The Cycle Between Angiogenesis, Perfusion, and Hypoxia in Tumors

    Dewhirst, Mark W. (et al.)

    Pages 27-47

  • The Role of Integrins in Tumor Angiogenesis

    Aiyer, Aparna R. (et al.)

    Pages 49-71

  • Tumor Endothelial Cell Abnormalities

    Dudley, Andrew C. (et al.)

    Pages 73-84

  • The Extracellular Matrix and VEGF Processing

    Lee, Sunyoung (et al.)

    Pages 85-97

Buy this book

eBook $249.00
price for USA (gross)
  • ISBN 978-1-59745-184-0
  • Digitally watermarked, DRM-free
  • Included format: PDF
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover $319.00
price for USA
  • ISBN 978-1-58829-870-6
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Loading...

Recommended for you

Loading...

Bibliographic Information

Bibliographic Information
Book Title
Antiangiogenic Agents in Cancer Therapy
Editors
  • Beverly A. Teicher
  • Lee M. Ellis
Series Title
Cancer Drug Discovery and Development
Copyright
2008
Publisher
Humana Press
Copyright Holder
Humana Press
eBook ISBN
978-1-59745-184-0
DOI
10.1007/978-1-59745-184-0
Hardcover ISBN
978-1-58829-870-6
Series ISSN
2196-9906
Edition Number
2
Number of Pages
XVIII, 559
Topics